A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety

Clinical trial NCT04644484 · COMPLETED

Trial details

NCT number: NCT04644484
Sponsor: Synermore Biologics (Suzhou) Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rabies Communicable Disease Virus Diseases Rhabdoviridae Infections Mononegavirales Infections RNA Virus Infections

Start date: 2020-09-23
Primary completion: 2022-06-24
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.